Precision Medicine in Otorhinolaryngology: A New Challenge to Improve Outcomes in ENT Disease

Dear Colleagues,

We are pleased to announce the launch of a new Special Issue, “Precision Medicine in Otorhinolaryngology: A New Challenge to Improve Outcomes in ENT Disease”, a continuation of a previously successfully Special Issue.

Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. It represents an exciting opportunity to improve the future of individualised healthcare for patients. One of the aims of personalized medicine is to improve efficiency and quality of care, while reducing side effects. In the last few years, our increased knowledge about the classification of diseases on a molecular level has been the basis for personalized medicine in otorhinolaryngology, especially in the field of chronic disease, increasing long-term control.

Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. Introduced in the field of oncology, it is now considered of major interest in other medical domains, such as allergy chronic airway diseases, which face an urgent need to improve the level of disease control, enhance patient satisfaction and increase effectiveness of preventive interventions. Physicians treating patients with chronic disorders might find precision medicine extremely useful to find reports on the predictors of success of medical or surgical interventions. Prediction of the success of treatments is crucial to allow the patient to become an active partner in the decision-making process of medical or surgical treatment.

In the last few years, in the field of audiology, the potential application of precision medicine in hearing loss has been discussed. By integrating precision medicine principles into translational hearing loss research and clinical practice, hearing specialists are uniquely positioned to effectively treat the heterogeneous causes and manifestations of HL on an individualized basis.

The combination of personalized care, prediction of treatment success, prevention of disease and patient participation in the elaboration of treatment plans is expected to substantially improve the therapeutic approach for individuals suffering from chronic disabling conditions.

Several factors are driving the increased interest in precision medicine in otorhinolaryngology. Rhinology, head and neck cancers and hearing loss, as well as some other otolaryngology-related conditions, represent an opportunity to use precision-guided therapies. For this reason, we proposed this Special Issue of the Journal of Personalized Medicine in order to collect papers about personalized medicine in all the fields of otorhinolaryngology. This Special Issue will include studies that explore new aspect of personalized medicine using basic science, clinical and population-based approaches.

Dr. Eugenio De Corso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.